Canton Strategic Holdings (CNTN) Shares Issued (2020 - 2026)
Canton Strategic Holdings (CNTN) posted Shares Issued of $656163.0 for Q1 2026, little changed on a QoQ basis from $657042.0 in Q4 2025, and up 170.26% year-over-year from $242788.0 in Q1 2025.
Canton Strategic Holdings (CNTN) Shares Issued (2020 - 2026) Analysis & Trends
Canton Strategic Holdings' Shares Issued history runs 7 years deep, the most recent figure standing at $656163.0 for Q1 2026.
- Quarterly Shares Issued rose 170.26% year-over-year to $656163.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $656163.0 (up 170.26% YoY) and the FY2025 annual result came in at $657042.0, up 503.04% from the prior year.
- Shares Issued was $656163.0 for Q1 2026 at Canton Strategic Holdings, roughly flat from $657042.0 in the prior quarter.
- Across five years, Shares Issued topped out at $1.8 million in Q1 2022 and bottomed at $5323.0 in Q2 2024.
- A 5-year average of $436437.9 and a median of $240910.5 in 2025 frame the typical range for Shares Issued.
- Annual changes were most pronounced in 2025 — Shares Issued surged 4390.57% — and 2026, when it jumped 170.26%.
- Canton Strategic Holdings' Shares Issued stood at $1.8 million in 2022, then tumbled by 99.66% to $6102.0 in 2023, then soared by 1685.56% to $108955.0 in 2024, then jumped by 503.04% to $657042.0 in 2025, then decreased by 0.13% to $656163.0 in 2026.
- Business Quant data shows CNTN's Shares Issued at $656163.0 in Q1 2026, $657042.0 in Q4 2025, and $607042.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,102.16 Bn | 67,101.87 Bn | - | - |
| 2 | Nanobiotix | 1,908.96 Bn | 1,908.90 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | 154.50 Mn |
| 4 | BeOne Medicines | 474.03 Bn | 469.24 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 122.13 Bn | 114.88 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 70.09 Bn | 61.34 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - | - |
| 8 | Argenx Se | 55.96 Bn | 50.77 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.53 Bn | 34.52 Bn | 959.66 Mn | - |
| 10 | Canton Strategic Holdings | 426.84 Mn | 426.84 Mn | - | 656,163.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 656,163.00 |
| Mar 31, 2026 | 656,163.00 |
| Dec 31, 2025 | 657,042.00 |
| Dec 31, 2025 | 657,042.00 |
| Sep 30, 2025 | 607,042.00 |
| Sep 30, 2025 | 607,042.00 |
| Jun 30, 2025 | 239,033.00 |
| Jun 30, 2025 | 239,033.00 |
| Mar 31, 2025 | 242,788.00 |
| Mar 31, 2025 | 242,788.00 |
| Dec 31, 2024 | 108,955.00 |
| Dec 31, 2024 | 108,955.00 |
| Sep 30, 2024 | 22,592.00 |
| Sep 30, 2024 | 22,592.00 |
| Jun 30, 2024 | 5,323.00 |
| Jun 30, 2024 | 5,323.00 |
| Dec 31, 2023 | 6,102.00 |
| Dec 31, 2023 | 6,102.00 |
| Mar 31, 2022 | 1.82 Mn |
| Mar 31, 2022 | 1.82 Mn |